| Insider · 14 positions | Net Shares per Quarter (+ Bought / − Sold) | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Name | Role | Shares Held ↓ | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
| Jay R. Luly | President and CEO | 878K | — | — | +14K | -7K | — | — | — | — | — | — | — | — | — | — | — | — |
| Yat Sun Or | Chief Scientific Officer | 378K | — | — | +3K | -3K | — | — | — | — | — | — | — | — | — | — | — | — |
| Brendan Luu | Chief Business Officer | 45K | — | — | +3K | -2K | — | — | — | — | — | — | — | — | — | — | — | — |
| Tara Lynn Kieffer | Chief Product Strategy Officer | 37K | — | — | +3K | -3K | — | — | — | — | — | — | — | — | — | — | — | — |
| Scott T. Rottinghaus | Chief Medical Officer | 24K | -1K | — | +3K | -798 | — | — | — | — | — | — | — | — | — | — | — | — |
| Terry Vance | — | 20K | — | — | +20K | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Lesley Russell | — | 20K | — | — | +20K | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Kristine Peterson | — | 20K | — | — | +20K | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Yujiro S Hata | — | 20K | — | — | +20K | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Mark G Foletta | — | 20K | — | — | +20K | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Bruce L A Carter | — | 20K | — | — | +20K | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Harry R. Trout III | Vice President, Finance (Principal Financial Officer) | 16K | — | — | — | -1K | — | — | — | — | — | — | — | — | — | — | — | — |
| Kathleen S. Capps | Executive Director of Accounting, Controller (Principal Accounting Officer) | 8K | — | — | — | -615 | — | — | — | — | — | — | — | — | — | — | — | — |
| Matthew Paul Kowalsky | Chief Legal Officer | 5K | — | — | +4K | — | — | — | — | — | — | — | — | — | — | — | — | — |